| Original language | English (US) |
|---|---|
| Pages (from-to) | 90-92 |
| Number of pages | 3 |
| Journal | Hellenic Journal of Cardiology |
| Volume | 64 |
| DOIs | |
| State | Published - Mar 1 2022 |
Keywords
- angioplasty
- coronary artery disease
- percutaneous coronary
- race
- transluminal
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) according to race : Insights from the PROGRESS-CTO registry. / Vemmou, Evangelia; Nikolakopoulos, Ilias; Karacsonyi, Judit; Kostantinis, Spyros; Rangan, Bavana Venkata; Baechler, Courtney; Garcia, Santiago; Burke, M. Nicholas; Alaswad, Khaldoon; Brilakis, Emmanouil S.
In: Hellenic Journal of Cardiology, Vol. 64, 01.03.2022, p. 90-92.Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) according to race
T2 - Insights from the PROGRESS-CTO registry
AU - Vemmou, Evangelia
AU - Nikolakopoulos, Ilias
AU - Karacsonyi, Judit
AU - Kostantinis, Spyros
AU - Rangan, Bavana Venkata
AU - Baechler, Courtney
AU - Garcia, Santiago
AU - Burke, M. Nicholas
AU - Alaswad, Khaldoon
AU - Brilakis, Emmanouil S.
N1 - Funding Information: Dr. Brilakis: consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Amgen, Asahi Intecc, Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), ControlRad, CSI, Ebix, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens ; owner, Hippocrates LLC; shareholder: MHI Ventures, Cleerly Health. Funding Information: Dr. Garcia: Institutional research grants from Edwards Lifesciences , Medtronic , Abbott Vascular , Biotronik and BSCI . Consultant: Neochord, Abbott Vascular, Medtronic and BSCI. Proctor: Edwards Lifesciences. Funding Information: This work was funded by an Abbott Northwestern Hospital Foundation Innovation Grant and a gift from the Joseph F. and Mary M. Fleischhacker Foundation .
PY - 2022/3/1
Y1 - 2022/3/1
KW - angioplasty
KW - coronary artery disease
KW - percutaneous coronary
KW - race
KW - transluminal
UR - http://www.scopus.com/inward/record.url?scp=85127095193&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127095193&partnerID=8YFLogxK
U2 - 10.1016/j.hjc.2021.07.007
DO - 10.1016/j.hjc.2021.07.007
M3 - Letter
C2 - 34311103
AN - SCOPUS:85127095193
VL - 64
SP - 90
EP - 92
JO - Hellenic Journal of Cardiology
JF - Hellenic Journal of Cardiology
SN - 1109-9666
ER -